|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
|
|---|---|---|---|---|
| Assets | ||||
| Current assets | ||||
| Cash | ||||
| Prepaid expenses | ||||
| Prepaid insurance | ||||
| Total current assets | ||||
| Long-term prepaid insurance | ||||
| Marketable securities held in Trust Account | ||||
| Deferred offering costs | ||||
| Total Assets | ||||
| Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit | ||||
| Liabilities | ||||
| Current liabilities | ||||
| Accrued expenses | ||||
| Accounts payable and accrued expenses | ||||
| Accrued offering costs | ||||
| Advances from related party | ||||
| Promissory notes – related parties | ||||
| Total current liabilities | ||||
| Deferred underwriting fee | ||||
| Total Liabilities | ||||
| Ordinary shares subject to possible redemption, $0.0001 par value; 11,500,000 shares at redemption value of $10.25 and $10.07 per share at June 30, 2026 and December 31, 2025, respectively | ||||
| Class A Ordinary Shares | ||||
| Total ordinary shares subject to possible redemption, $0.0001 par value; 11,500,000 shares at redemption value of $10.25 and $10.07 per share at June 30, 2026 and December 31, 2025, respectively | ||||
| Shareholders’ Deficit | ||||
| Ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 4,213,333 shares issued and outstanding (excluding 11,500,000 shares subject to possible redemption) at June 30, 2026 and December 31, 2025 | ||||
| Class B Ordinary Shares | ||||
| Total ordinary shares, $0.0001 par value; 200,000,000 shares authorized; 4,213,333 shares issued and outstanding (excluding 11,500,000 shares subject to possible redemption) at June 30, 2026 and December 31, 2025 | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| Total Liabilities, Ordinary Shares Subject to Possible Redemption, and Shareholders’ Deficit |
Loading...
